CrossrefInfokarte
Modest effect of delgocitinib to recalcitrant chronic hand eczema
Clinical and Experimental Dermatology · 2026-11-11
DOI: 10.1093/ced/llag472 ↗Abstract
Topical delgocitinib demonstrated limited efficacy after 8 weeks of treatment in 14 patients with chronic, treatment-resistant moderate-to-severe chronic hand eczema (CHE). The observed treatment response was lower than that reported in previous clinical trials, and no significant predictors of response were identified.
EUVIMED